Predicting Myelotoxicity in Radioimmunotherapy: What Does Dosimetry Contribute?

Pat Zanzonico; George Sgouros

EditorialNuclear Oncology

Predicting Myelotoxicity in Radioimmunotherapy: What Does Dosimetry Contribute?

Pat Zanzonico and George Sgouros

Journal of Nuclear Medicine November 1997, 38 (11) 1753-1754;

Pat Zanzonico

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

George Sgouros

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 38, Issue 11

November 1, 1997

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Predicting Myelotoxicity in Radioimmunotherapy: What Does Dosimetry Contribute?

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.